Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
D. L. Sparks, D. J. Connor, M. N. Sabbagh, R. B. Petersen, J. Lopez, P. Browne
Research output: Contribution to journal › Article › peer-review
115Scopus
citations
Fingerprint
Dive into the research topics of 'Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial'. Together they form a unique fingerprint.